Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R1AB
|
||||
Former ID |
DNC013310
|
||||
Drug Name |
H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]-OH
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528875] | ||
Structure |
Download2D MOL |
||||
Formula |
C28H35N5O7
|
||||
Canonical SMILES |
C1CCC(NC(=O)C(NC(=O)CNC(=O)C(C1)NC(=O)C(CC2=CC=C(C=C2)O<br />)N)CC3=CC=CC=C3)C(=O)O
|
||||
InChI |
1S/C28H35N5O7/c29-20(14-18-10-12-19(34)13-11-18)25(36)32-21-8-4-5-9-22(28(39)40)33-27(38)23(15-17-6-2-1-3-7-17)31-24(35)16-30-26(21)37/h1-3,6-7,10-13,20-23,34H,4-5,8-9,14-16,29H2,(H,30,37)(H,31,35)(H,32,36)(H,33,38)(H,39,40)/t20-,21+,22+,23-/m0/s1
|
||||
InChIKey |
GDFBPHMKQXUQTN-AFXVXQJMSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528875] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [528875] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528875] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.